Appropriateness of ketorolac use in a trauma hospital;Adecuación del uso de ketorolaco en un hospital de traumatología

Revista de Calidad Asistencial

Volumn 24, Issue 3, 2009, Pages 115-123

  Angeles Gonzalez Fernandez M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Ketorolac; NSAIDs; Patient safety; PDCA cycle

Indexed keywords

KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG UTILIZATION; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; MALE; MIDDLE AGED; PRESCRIPTION; RETROSPECTIVE STUDY; STANDARD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; KETOROLAC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRAUMA CENTERS; YOUNG ADULT;

EID: 67649224901     PISSN: 1134282X     EISSN: 18871364     Source Type: Journal    
DOI: 10.1016/S1134-282X(09)71140-6     Document Type: Article

References (31)

1. Agencia Española del Medicamento y Productos Sanitarios; 27 de septiembre de 2006. Actualización sobre la evaluación de riesgos de los AINE tradicionales y medidas reguladoras previstas [citado Dic 2007]. Disponible en: http://www.agemed.es/actividad/alertas/usoHumano/seguridad/AINE-sept06.htm
2. Agencia Española del Medicamento y Productos Sanitarios; 7 de febrero de 2007 [citado Dic 2007]. Disponible en: http://www.agemed.es/actividad/alertas/usoHumano/seguridad/2007- 02_NI_ketorolaco-web.htm
3. Font Noguera I., López Briz E., Ordovás Baines J.P., Ruiz Guinaldo C., and Sirvent Ochando M. Evaluación y mejora de la calidad asistencial de los Servicios de Farmacia Hospitalaria en la Comunidad Valenciana. Programa VALOR en Farmacia Hospitalaria (2002), Conselleria de Sanitat, Subsecretaria per a l'Agència Valenciana de la Salut, Valencia
4. Jiménez Torres N.V., and Climente Martí M. La atención farmacéutica: premisa para la calidad asistencial. Rev Calid Asist 13 (1998) 83-90
5. a ed. (1996), Chapman & Hall, New York
6. Nimmo C.M., and Hilland R.W. Transitions in pharmacy practice, part 4: can a leopard change its spots?. Am J Hosp Pharm 51 (1994) 2022-2030
7. a ed. (1999), Mayo, Barcelona
8. Deming W.E. Calidad, productividad y competitividad. La salida de la crisis (1997), Díaz de Santos, Madrid
9. Ramírez J. Diagrama causa efecto. Disponible en: http://www.monografias.com/trabajos42/diagrama-causa-efecto/diagrama-causa-efecto.shtml
10. Ficha Técnica Ketorolaco. Catálogo de Medicamentos. Colección Consejo Plus 2008. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2008. p. 2038-39.
11. Willett L.R., Carson J.L., and Strom B.L. Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflamatory drugs. Drug Safety 10 (1994) 170-181
12. Hayllar J., Macpherson A., and Bjarnason I. Gastroprotection and non-steroidal anti-inflammatory drugs (NSAIDs): rationale and clinical implications. Drug Safety 7 (1992) 86-105
13. García Rodríguez L.A., Cattaruzza C., Troncon M., et al. Risk of hospitalisation for UGI bleeding associated with ketorolac, other NSAIDS, calcium antagonists, and antihypertensive drugs. Arch Intern Med 158 (1998) 33-39
14. Lanas A., Serrano P., Bajador E., Fuentes J., and Sáinz R. Risk of upper gastrointestinal bleeding associated with nonaspirin cardiovascular drugs, analgesics and non-steroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol 15 (2003) 173-178
15. Laporte J.R., Ibañez L., Vidal X., Vendrell L., and Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs - newer versus older agents. Drug Safety 27 (2004) 411-420
16. Traversa G., Walker A., Ippolito F., et al. Gastroduodenal toxicity of different NSAIDs. Epidemiology 6 (1995) 49-54
17. Menniti-Ippolito F., Maggini M., Rashetti R., et al. Ketorolac use in outpatients and GI hospitalisations. Eur J Clin Pharmacol 54 (1998) 393-397
18. Llorente-Melero M.J., Tenías Burillo J.M., and Zaragoza Marcet A. Comparación del riesgo de hemorragia digestiva alta asociado a diferentes anti-inflamatorios no esteroideos. Rev Esp Enferm Dig 94 (2002) 7-12
19. Gallerani M., Simonato M., Manfredini R., Volpato S., Vigna, and Fellin R. Risk of hospitalization for upper gastrointestinal tract bleeding. J Clin Epidemiol 57 (2004) 103-110
20. Lanas A., García-Rodríguez L.A., Arroyo M.T., et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclooxigenase-2 inhibitors, traditional non-aspirin NSAIDs, aspirin and combinations. Gut 55 (2006) 1731-1738
21. Ballantyne J.C., Carr D.B., De Ferrandi S., Suarez T., Lau J., Chalmers T.C., et al. The comparative effects of post-operative analgesic therapies on pulmonare outcome: cumulative meta-analyses on randomized, controlled trials. Anesth Analg 86 (1998) 598-612
22. Saviola G., Ambrosio F., Paoletti F., Bertini C., Mattia B., Amantea L., et al. SIAARTI recommendations for the treatment of postoperative pain. SIAARTI Study Group for Acute/Chronic pain. Minerva Anestesiol 68 (2002) 735-750
23. Rosenquist R., and Rosenberg J. Postoperative pain guidelines. Reg Anesth Pain Med 28 (2003) 279-288
24. Hyllested M., Jones S., Pedersen J.L., and Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth 88 (2002) 199-214
25. Lagman M.J.S., Weil J., and Wainwright P. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflamatory drugs. Lancet 343 (1994) 1075-1078
26. Practice guidelines for acute pain management in the perioperative setting. An updated Report by the American Society of Anesthesiologists Task Force on Acute pain management. Anesthesiology. 2004;100:1573-81.
27. Soll A.H., Weinstein W.M., and Kurata J. Nonsteroidal anti-inflamatory drugs and peptic ulcer disease. Ann Intern Med 114 (1991) 307-319
28. Griffein M.R., Piper J.M., and Daughery J.R. Nonsteroidal anti-inflammatory drug use and increased risk of peptic ulcer disease in elderly persons. Ann Intern Med 114 (1991) 257-263
29. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclear J.r., and Beers M.H. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163 (2003) 2716-2724
30. Ficha técnica Ketorolaco. Catálogo de especialidades farmacéuticas. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2000. p. 1963-4.
31. a ed. (2002), SCM-Doyma, Barcelona 541-573